{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:10:14Z","timestamp":1778303414376,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jinf.2025.106490","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T22:45:44Z","timestamp":1745534744000},"page":"106490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006\/07-2017\/18"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-1172","authenticated-orcid":false,"given":"Marta","family":"Bertran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariyo","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-9886","authenticated-orcid":false,"given":"Joshua C.","family":"D\u2019Aeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahin","family":"Amin-Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyi","family":"Eletu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Litt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-3969","authenticated-orcid":false,"given":"Godwin","family":"Oligbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-2476","authenticated-orcid":false,"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106490_bib1","unstructured":"Centers for Disease Control and Prevention, United States. Global Pneumococcal Disease and Vaccine 2020. Available from: https:\/\/www.cdc.gov\/pneumococcal\/global.html."},{"issue":"11","key":"10.1016\/j.jinf.2025.106490_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106490_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large fragment from an oral Streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.jinf.2025.106490_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106490_bib5","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1473-3099(20)30492-8","article-title":"Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK","volume":"21","author":"Ladhani","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"40","key":"10.1016\/j.jinf.2025.106490_bib6","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/j.vaccine.2021.08.095","article-title":"Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991-2016","volume":"39","author":"Malo","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2025.106490_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106490_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2025.106490_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/INF.0000000000001845","article-title":"Characteristics of children with invasive pneumococcal disease after the introduction of the 13-valent pneumococcal conjugate vaccine in England and Wales, 2010-2016","volume":"37","author":"Makwana","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jinf.2025.106490_bib10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/INF.0b013e31805ce277","article-title":"Recurrent systemic pneumococcal disease in children","volume":"26","author":"Mason","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.jinf.2025.106490_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/00365548.2013.877156","article-title":"Recurrent invasive pneumococcal disease in children: epidemiological, microbiological, and clinical aspects from a Danish 33-year nationwide survey (1980-2013)","volume":"46","author":"Ingels","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106490_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118848","article-title":"Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics","volume":"10","author":"Alsina","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.jinf.2025.106490_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/377736","article-title":"Recurrent invasive pneumococcal disease: A population-based assessment","volume":"37","author":"King","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2025.106490_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1469-0691.2005.01221.x","article-title":"Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection","volume":"11","author":"Einarsd\u00f3ttir","year":"2005","journal-title":"Clin Microbiol Infect: Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106490_bib15","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1097\/INF.0000000000003454","article-title":"Clinical presentations and outcomes of children in Canada with recurrent invasive pneumococcal disease from the IMPACT surveillance network","volume":"41","author":"Murad","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.jinf.2025.106490_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2025.106490_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106490_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(23)00706-5","article-title":"Invasive pneumococcal disease 3 years after introduction of a reduced 1+1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study","volume":"24","author":"Bertran","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106490_bib19","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/cid\/ciaa1728","article-title":"Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England","volume":"72","author":"Amin-Chowdhury","year":"2021","journal-title":"Clin Infect Dis: Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jinf.2025.106490_bib20","series-title":"Pneumococcal: The Green Book","article-title":"Immunisation against infectious diseases","year":"2013"},{"issue":"3","key":"10.1016\/j.jinf.2025.106490_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s15010-013-0571-3","article-title":"Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period","volume":"42","author":"Sanz","year":"2014","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.jinf.2025.106490_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12879-018-3267-6","article-title":"Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease","volume":"18","author":"Ingels","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2025.106490_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/INF.0000000000000701","article-title":"Immunodeficiency among children with recurrent invasive pneumococcal disease","volume":"34","author":"Ingels","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.jinf.2025.106490_bib24","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20070628","article-title":"Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity","volume":"204","author":"Ku","year":"2007","journal-title":"J Exp Med"},{"issue":"5889","key":"10.1016\/j.jinf.2025.106490_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.1158298","article-title":"Pyogenic bacterial infections in humans with MyD88 deficiency","volume":"321","author":"von Bernuth","year":"2008","journal-title":"Sci (N Y, NY)"},{"issue":"2","key":"10.1016\/j.jinf.2025.106490_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis: Publ Infect Dis Soc Am"},{"issue":"7","key":"10.1016\/j.jinf.2025.106490_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","article-title":"Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2025.106490_bib28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1086\/339882","article-title":"Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection","volume":"185","author":"McEllistrem","year":"2002","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106490_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:14:33Z","timestamp":1778300073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325000842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0163445325000842"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106490","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent invasive pneumococcal disease in children: A retrospective cohort study, England, 2006\/07-2017\/18","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106490"}}